Home › Funds › Millennium Management › IMVT
Millennium Management position in IMVT
IMMUNOVANT INC · Health Care
Latest position (Q2 2026)328.68K sh
Reported value held$12.66M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 460.13K | $4.00M | New |
| Q4 2021 | 337.97K | $2.88M | Reduce |
| Q1 2022 | 596.28K | $3.29M | Add |
| Q2 2022 | 333.55K | $1.30M | Reduce |
| Q3 2022 | 345.26K | $1.93M | Add |
| Q4 2022 | 82.44K | $1.46K | Reduce |
| Q1 2023 | 1.08M | $16.80K | Add |
| Q2 2023 | 664.65K | $12.61M | Reduce |
| Q3 2023 | 827.93K | $31.78M | Add |
| Q4 2023 | 795.10K | $33.50M | Reduce |
| Q1 2024 | 583.53K | $18.85M | Reduce |
| Q2 2024 | 275.35K | $7.27M | Reduce |
| Q3 2024 | 376.51K | $10.73M | Add |
| Q4 2024 | 167.10K | $4.14M | Reduce |
| Q1 2025 | 253.24K | $4.33M | Add |
| Q2 2025 | 251.17K | $4.02M | Reduce |
| Q3 2025 | 88.11K | $1.42M | Reduce |
| Q4 2025 | 172.50K | $4.38M | Add |
| Q2 2026 | 328.68K | $12.66M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMVT
- Fidelity Management & Research (FMR) 16.19M sh · $623.66M · Q2 2026
- BlackRock Inc 7.18M sh · $276.68M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- Vanguard Group 7.78M sh · $197.75M · Q4 2025
- Morgan Stanley 4.53M sh · $174.73M · Q2 2026
- Geode Capital Management 2.23M sh · $86.12M · Q2 2026
- Goldman Sachs Group 1.75M sh · $67.47M · Q2 2026
- D. E. Shaw & Co 1.24M sh · $47.80M · Q2 2026
- Bank of America Corp 1.18M sh · $45.52M · Q2 2026
- Northern Trust Corp 794.00K sh · $30.59M · Q2 2026
- Renaissance Technologies 726.80K sh · $28.00M · Q2 2026
- Charles Schwab Investment Management 680.59K sh · $26.22M · Q2 2026